A significant discovery in cancer investigation is emerging with the use of VHH fragments to re-engage damaged p53. This vital cancer inhibitor protein is frequently disabled in many forms of malignancies, leading https://bookmarkfriend.com/story21993467/mini-antibodies-revive-p53-a-new-pathway-for-tumor-management